
Yasuda Enterprise Development
Description
Yasuda Enterprise Development is a venerable venture capital firm based in Tokyo, Japan, with a rich history dating back to its founding in 1980. As one of Japan's earliest and most established VC players, the firm boasts over four decades of experience in identifying and nurturing innovative startups. Its investment mandate is notably broad, spanning from seed-stage companies to later-stage ventures, reflecting a comprehensive approach to supporting entrepreneurial growth across various development phases.
The firm's investment strategy is sector-agnostic to a degree, but it shows a clear preference for technology-driven sectors. Key areas of focus include information technology, biotechnology, and environmental technology, encompassing a wide range of sub-sectors like software, IT services, and healthcare. While primarily rooted in Japan, Yasuda Enterprise Development also actively seeks opportunities in the United States and other international markets, demonstrating a global outlook in its pursuit of high-potential companies.
Yasuda Enterprise Development manages significant capital, with total assets under management (AUM) reaching approximately US$196 million (¥30 billion) as of early 2024. This substantial capital base is deployed through various funds, including its recently established Yasuda Enterprise Development No. 6 Investment Limited Partnership, which closed with ¥15 billion (approximately US$98 million). The firm typically provides initial investments ranging from US$650,000 to US$6.5 million, positioning itself to support companies from their nascent stages through significant growth milestones. Its long-standing presence and strategic investments underscore its commitment to fostering innovation and contributing to industrial development both domestically and abroad.
Investor Profile
Yasuda Enterprise Development has backed more than 35 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 3% of its total and boasts 18 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Series Unknown, Series C rounds (top funding stages).
- Majority of deals are located in United States, Japan, United Kingdom.
- Strong thematic focus on Biotechnology, Medical, Health Care.
- Typical check size: $650K – $6.5M.
Stage Focus
- Series B (34%)
- Series Unknown (26%)
- Series C (20%)
- Series D (11%)
- Series A (3%)
- Series E (3%)
- Series F (3%)
Country Focus
- United States (66%)
- Japan (20%)
- United Kingdom (9%)
- Switzerland (3%)
Industry Focus
- Biotechnology
- Medical
- Health Care
- Pharmaceutical
- Manufacturing
- Electronics
- Information Technology
- Biopharma
- Semiconductor
- Hardware
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.